Drugs / PRP (Polyribosyl Ribitol Phosphate)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00127855 | Mar 2003 → Feb 2004 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP (Polyribosyl Ribitol Phosphate) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00127855 ↗ |
| Route | Intramuscular | “One dose was administered IM in deltoid region of left arm at Month 10 as booster” NCT00127855 ↗ |